Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Viralytics (ASX:VLA) has commenced a phase I trial of its Cavatak cancer treatment candidate in non-muscle invasive bladder cancer. The company ...
From its onset, cancer has not been diagnosed in enough detail and ... Unipathic Medicine also focuses on multiple immunotherapy cancer targets, ...
... identified microRNAs made by several herpes viruses that block a component of a human's innate immune system called the interferon response.
The company's immunotherapies, a new class of drugs that fights cancer with the help of the body's immune system, showed sales gains, Bristol said.
... be manipulated to help the body fight off specific infections or to help the immune system recognize cancer cells and leave healthy host cells alone.
Pancreatic cancer is a disease that frequently presents no symptoms until it reaches ... “Today we know more about this form of cancer. ... But with the advent of these new therapies that boost the patient's own immune system, the ...
Jody Rosenblatt, Ph.D., , associate professor in the Department of Oncological Sciences at the University of Utah School of Medicine, and an ...
21st Century Oncology, the nation's leading provider of integrated cancer care, is pleased to announce a complimentary lecture about pancreatic ...
Cancer News in Science Daily
Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study.
A type of 'nocebo' response -- where patients perceive a lack of understanding or acceptance from their doctor -- could create anger and distress, physiological conditions that could worsen illness, a new research shows.
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or even dying from prostate cancer.
Despite enormous progress in cancer therapy, many patients still relapse because their treatment addresses the symptoms of the disease rather than the cause, the so-called stem cells. New work has given a tantalizing clue to a solution. Scientists report that the cell-cycle kinase CDK6 is required for activation of the stem cells responsible for causing leukemia.
43% of surveyed female meningioma survivors aged 25–44 yrs stated they were warned that pregnancy was a risk factor for meningioma recurrence. Nevertheless, these women were more likely to want a baby (70% vs 54%) and intend to have a baby (27% vs 12%) than same-age women in the general population.
Researchers create first mouse model of ovarian clear cell carcinoma using data from human cancer genome atlas. They show how when the genes ARID1A and PIK2CA are mutated in specific ways, the result is ovarian cancer 100 percent of the time. They show that a known drug can suppress tumor growth.
The efficacy and safety of the new fusion protein has been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients with ALL. Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer.
Lung cancer predicted to overtake breast cancer as leading cause of cancer death among European women in 2015
Death rates from lung cancer will exceed those for breast cancer for the first time among European women in 2015, according to the latest predictions. The study by researchers in Italy and Switzerland predicts that although the actual number of deaths from all cancers in the European Union will continue to rise due to growing populations and numbers of elderly people, the rate of cancer deaths will continue to decline overall, with some notable exceptions: lung cancer in women and pancreatic cancer in both sexes.
A breast cancer risk prediction model for African American women has been developed by scientists that found greater accuracy in predicting risk for the disease. The use of this model could result in increased eligibility of African Americans in breast cancer prevention trials.
More equitable delivery of evidence-based care can close a persistent racial disparity in colon cancer survival rates in the United States. African-American patients have consistently had lower survival rates when compared with white patients, despite a nationwide decline in colon cancer deaths overall.
New research shows why many cancers are difficult to treat and come back following treatment. Scientists have shown that cancer cells cooperate with each other in the production of growth factors (molecules produced by the cancer cells that are essential for tumor progression). It is hoped that the findings will lead to a new type of treatment involving genetically modified cancer cells being reinserted into a tumor.
Tambahkan Komentar